Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors
NCT06710821
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor Cancer
Interventions
DRUG:
Liposomal irinotecan in combination with vincristine and temozolomide
Sponsor
Yizhuo Zhang